Live Analyst Rating Changes 26923 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Evie Koslosky
GS

Evie Koslosky

Goldman Sachs
Wall Street Analyst
★★★★★
#274
on 13Foresight · ranked by our own returns
74%
Success Rate
+8.3%
Average Return
20 of 27 calls profitable · +5.2% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 74% of Evie Koslosky's ratings turned a profit when each position was held for 1 year — averaging +8.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

21 Buy 9 Hold 4 Sell
Evie's Stock Coverage 12 ratings · 2026-08-23
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SHC
Sotera Health
 Aug 06, 2026 BUY Strong Buy
+11.7% avg upside
13 analysts
$24.00
22.58% Upside
 -0.1% ·
DHR
Danaher
 Aug 03, 2026 BUY Strong Buy
-3.7% avg upside
45 analysts
$210.00
4.05% Downside
 +10.8% ·
GH
Guardant Health
 Jul 31, 2026 BUY Strong Buy
-4.0% avg upside
31 analysts
$210.00
23.13% Upside
 +5.4% ·
MTD
Mettler-Toledo
 Jul 31, 2026 HOLD Buy
-13.0% avg upside
18 analysts
$1340.00
4.06% Downside
 +0.6% ·
BRKR
Bruker
 Jul 27, 2026 SELL Buy
-4.4% avg upside
22 analysts
$40.00
32.87% Downside
 +0.8% ·
NTRA
Natera
 Jul 14, 2026 HOLD Strong Buy
-6.9% avg upside
27 analysts
$270.00
18.69% Downside
 +21.8% ·
WAT
Waters
 Jul 14, 2026 BUY Strong Buy
-4.0% avg upside
31 analysts
$425.00
3.54% Upside
 +9.1% ·
CAI
Caris Life Sciences, Inc.
 Jul 01, 2026 BUY Strong Buy
+5.9% avg upside
20 analysts
$27.00
2.73% Upside
 +40.1% ·
GRAL
GRAIL Inc
 Jun 05, 2026 HOLD Strong Buy
-12.9% avg upside
8 analysts
$60.00
24.63% Downside
 +18.2% ·
A
Agilent
 May 27, 2026 BUY Strong Buy
-6.3% avg upside
33 analysts
$155.00
2.48% Downside
 +37.5% ·
RVTY
Revvity
 May 06, 2026 HOLD Buy
-12.7% avg upside
23 analysts
$100.00
19.79% Downside
 +20.6% ·
TMO
Thermo Fisher
 Dec 09, 2025 BUY Strong Buy
-3.8% avg upside
38 analysts
$685.00
8.94% Upside
 +12.1% ·
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Evie Koslosky — Frequently Asked Questions
How accurate are Evie Koslosky's stock ratings?
Based on the calls 13Foresight could measure, about 74% of Evie's ratings were profitable over a one-year hold, with an average return of +8.3% per rating, or +5.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Evie ranked on 13Foresight?
Evie Koslosky is currently ranked #274 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Evie cover?
Evie most recently has ratings on SHC, DHR, GH, MTD, BRKR, NTRA, WAT, CAI, GRAL, A, RVTY, TMO. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.